drugset / Trial / NCT00863161
Renal Impairment Study
Non-randomizedSingle-groupOpen-labelBasic science
Summary
The purpose of this study is to see how quickly AZD3355 is taken up in to the blood and leaves the blood in people with normal kidney function or with different degrees of reduced kidney function.
Timeline
- Start
- 2009-03
- Primary completion
- 2010-02
- Completion
- 2010-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | lesogaberan | Small molecule | 130 mg | Oral |